Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
2,888.00    -9.00 (-0.31%)
Bid:
2,887.00
Ask:
2,889.00
Spread: 2.00 (0.069%)
Market Cap: £4.02b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Completed divestment

1 Jul 2022 07:00

RNS Number : 9187Q
Croda International PLC
01 July 2022
 

Stock market announcement

1 July 2022

Completed divestment - transitioning to a pure-play Consumer Care and Life Sciences company

Croda International Plc ('Croda'), which uses smart science to create high performance ingredients and technologies that improve lives, today announces the completion of the divestment of the majority of its Performance Technologies and Industrial Chemicals businesses to a wholly owned subsidiary of Cargill Inc ('Cargill'), as more fully described in Croda's initial announcement on 22 December 2021.

The gross proceeds will be approximately €775m (approximately £667m), subject to small, customary adjustments for cash and debt-like instruments, and working capital, in line with the earlier announcement. The divestment and the associated proceeds exclude Croda Sipo ('Sipo'), a Chinese joint venture in which Croda has a 65% shareholding. Croda continues to discuss with its joint venture partner the acquisition of its stake in Sipo, to enable a subsequent sale by Croda to Cargill of 100% of Sipo for €140m. 

Steve Foots, Chief Executive of Croda, said: "This divestment accelerates Croda's transition to being a pure-play Consumer Care and Life Sciences company. We will redeploy capital and resources to scale our consumer, health and crop care technologies, helping to deliver consistent, superior sales growth and even stronger profit margins."

 

Further information

For enquiries contact:

Investors: David Bishop, Croda +44 7823 874428

Press: Charlie Armitstead, Teneo +44 7703 330269

 

Advisers to Croda

 

Morgan Stanley & Co. International Plc (Financial Adviser & Corporate Broker)

Shirav Patel, Andrew Foster

Centerview Partners (Financial Adviser)

James Hartop

Freshfields Bruckhaus Deringer (Legal Adviser)

Oliver Lazenby

Teneo (Financial PR)

Charlie Armitstead

 

Disclaimers

 

Morgan Stanley & Co. International plc ("Morgan Stanley") which is authorised by the Prudential Regulation Authority ("PRA") and regulated by the Financial Conduct Authority and the PRA in the UK is acting exclusively as financial adviser and corporate broker to Croda and no one else in connection with the matters set out in this announcement. In connection with such matters, Morgan Stanley, its affiliates and their respective directors, officers, employees and agents will not regard any other person as their client, nor will they be responsible to any other person for providing the protections afforded to their clients or for providing advice in relation to the contents of this announcement or any other matter referred to herein.

 

Centerview Partners UK LLP ("Centerview Partners") is authorised and regulated by the Financial Conduct Authority. Centerview Partners is acting exclusively for Croda and no one else in connection with the matters referred to in this announcement. Centerview Partners is not and will not be responsible to anyone other than Croda for providing the protections afforded to its clients or for providing advice in connection with the contents of this announcement or any other matter referred to in this announcement. Neither Centerview Partners, nor any of its affiliates, owes or accepts any duty, liability or responsibility whatsoever to any person who is not a client of Centerview Partners in connection with this announcement, any statement contained herein or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISFMMRTMTIJBIT
Date   Source Headline
31st Oct 20165:31 pmRNSHolding(s) in Company
31st Oct 20163:17 pmRNSDirector/PDMR Shareholding
18th Oct 20169:15 amRNSHolding(s) in Company
12th Oct 20167:01 amRNSDirector Declaration
11th Oct 20165:44 pmRNSDirector/PDMR Shareholding
7th Oct 20164:06 pmRNSHolding(s) in Company
6th Oct 20165:32 pmRNSHolding(s) in Company
5th Oct 20165:54 pmRNSDirector/PDMR Shareholding
5th Oct 20163:47 pmRNSHolding(s) in Company
16th Sep 201611:50 amRNSDirector/PDMR Shareholding
13th Sep 20165:30 pmRNSHolding(s) in Company
13th Sep 20164:49 pmRNSDirector/PDMR Shareholding
12th Sep 20165:07 pmRNSHolding(s) in Company
11th Aug 20163:01 pmRNSDirector/PDMR Shareholding
5th Aug 20164:51 pmRNSHolding(s) in Company
5th Aug 20163:28 pmRNSDirector/PDMR Shareholding
4th Aug 20169:40 amRNSHolding(s) in Company
2nd Aug 20165:17 pmRNSHolding(s) in Company
2nd Aug 20165:13 pmRNSHolding(s) in Company
27th Jul 20165:28 pmRNSHolding(s) in Company
26th Jul 20167:00 amRNSResults for the six months ended 30 June 2016
13th Jul 20163:22 pmRNSDirector/PDMR Shareholding
12th Jul 20165:35 pmRNSHolding(s) in Company
11th Jul 20162:23 pmRNSHolding(s) in Company
8th Jul 201610:50 amRNSHolding(s) in Company
13th Jun 20168:00 amRNSDirector/PDMR Shareholding
7th Jun 201612:25 pmRNSDirector/PDMR Shareholding
31st May 20169:54 amRNSHolding(s) in Company
11th May 20163:49 pmRNSDirector/PDMR Shareholding
3rd May 20165:16 pmRNSHolding(s) in Company
29th Apr 201612:22 pmRNSDirector/PDMR Shareholding
28th Apr 20164:00 pmRNSTransaction in Own Shares
28th Apr 201612:09 pmRNSHolding(s) in Company
28th Apr 201612:06 pmRNSResult of AGM
27th Apr 20167:00 amRNSTrading update for the first quarter of 2016
25th Apr 201610:57 amRNSDirector/PDMR Shareholding
12th Apr 20162:46 pmRNSDirector/PDMR Shareholding
4th Apr 20165:41 pmRNSHolding(s) in Company
31st Mar 20164:52 pmRNSHolding(s) in Company
21st Mar 20165:45 pmRNSAnnual Financial Report
21st Mar 20163:20 pmRNSDirector/PDMR Shareholding
21st Mar 20163:19 pmRNSHolding(s) in Company
17th Mar 20167:00 amRNSCapital Markets Event
14th Mar 201612:07 pmRNSHolding(s) in Company
11th Mar 20164:12 pmRNSDirector/PDMR Shareholding
10th Mar 20169:59 amRNSDirector/PDMR Shareholding
7th Mar 20162:51 pmRNSDirector/PDMR Shareholding
3rd Mar 20164:52 pmRNSHolding(s) in Company
29th Feb 20165:03 pmRNSHolding(s) in Company
23rd Feb 20167:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.